Annual Report 2020

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2020 137 The United Laboratories International Holdings Limited Annual Report 2020 39. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) The tables below detail the credit risk exposures of the Group’s financial assets at 31 December 2020 and 2019 which are subject to ECL assessment: External Internal Gross credit credit 12m or carrying 2020 Notes rating rating lifetime ECL amount RMB’000 Pledged bank deposits 25 A1 to Ba1 N/A 12m ECL 440,194 Other pledged deposits 29 A2 to A3 N/A 12m ECL 24,000 Bank balances 25 Aa1 to Ba1 N/A 12m ECL 2,996,527 Refundable deposits 24 N/A Note 1 12m ECL 3,340 Other receivables 24 N/A Note 1 12m ECL 98,386 Consideration receivables 24 N/A Note 3 Lifetime ECL (not credit-impaired) 308,388 Commercial bills receivables 24 N/A Note 3 Lifetime ECL (not credit-impaired) 244,110 Bills receivables 24 A1 to B1 N/A 12m ECL 1,343,365 Trade receivables 24 N/A Note 2 Lifetime ECL (provision matrix) 1,420,450